Viewing nowNebivolol Tablets (Nebivolol hydrochloride)
Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

MFDS item code 201103608 · Approved 2011.05.31 · Insurance code 670701630
Treatment of essential hypertension; adjunctive treatment of chronic heart failure in patients aged 70 years and older
This medication is used as an adjunct to standard therapy for essential hypertension and chronic heart failure, especially in patients aged 70 years and older with stable chronic heart failure of mild to moderate severity. It helps control blood pressure and improve heart function, contributing to the overall health status of patients.
Essential hypertension Adults: Nebivolol 5 mg orally once daily, at the same time each day. The blood pressure-lowering effect usually appears after 1 to 2 weeks of treatment, but may take 4 weeks in some cases. May be taken with food. Patients with renal impairment: The initial dose is nebivolol 2.5 mg orally once daily. If necessary, the daily dose may be increased to 5 mg. Elderly patients: The initial dose in patients aged 65 years or older is nebivolol 2.5 mg once daily. If necessary, the daily dose may be increased to 5 mg. Since clinical experience in patients aged 75 years or older is limited, administer with careful monitoring. Chronic heart failure Patients aged 70 years or older: This medicine should be administered to patients with chronic stable heart failure who have had no history of acute heart failure during the previous 6 weeks. The doses of cardiovascular medicines, such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers, should be stabilized up to 2 weeks before starting this medicine. The dose should be increased gradually at 1- to 2-week intervals until the optimal dose for each patient is reached, taking the patient's condition into consideration. Treatment should be initiated with nebivolol 1.25 mg once daily and, if necessary, may be increased to 2.5 mg once daily, 5 mg once daily, and then up to 10 mg once daily. The maximum daily dose is 10 mg. May be taken with food. Patients with renal impairment: Since titration to the maximum tolerated dose is adjusted for each individual patient, dose adjustment is not necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine ≥ 250 μmol/L), as there is no experience with use in these patients.
This medication should not be used in certain patients. For example, those who are allergic to this drug or have bronchial asthma, metabolic acidosis, bradycardia, or acute heart failure may be at risk when taking this medication. Also, individuals with severely impaired liver or kidney function, or women who are pregnant or breastfeeding should avoid this drug, as these conditions can significantly worsen side effects or the drug's effectiveness. Special caution should be exercised when this drug is used in patients with chronic pulmonary disease, heart failure, peripheral circulatory disorders, hyperthyroidism, diabetes, or the elderly. In such cases, careful monitoring and adjustments by a physician are required. During treatment, various side effects such as bradycardia, hypotension, worsening heart failure, dizziness, headache, dyspepsia, dyspnea, skin rash, and others may occur. Therefore, any unusual symptoms should be reported to healthcare providers immediately. This drug interacts with many other medications, so caution is needed when taken with calcium channel blockers, antiarrhythmics, central nervous system drugs, and hypoglycemics. Thus, inform your doctor or pharmacist if you are taking other medications. Pregnant or breastfeeding women are advised not to take this medication, particularly during early pregnancy due to potential side effects to the fetus. This medication is not recommended for children under 18 years, as its safety and efficacy have not been adequately confirmed. Elderly patients may have different responses to medication, so treatment should start at a low dose and be increased gradually while carefully monitoring blood pressure and heart rate. In case of overdose, severe bradycardia, hypotension, or bronchospasm may occur, necessitating immediate medical attention for appropriate treatment. Rapid measures such as gastric lavage, atropine administration, and blood pressure maintenance are required in case of an overdose.
Rash, vision impairment, bradycardia, AV block, AV conduction delay, hypotension, heart failure, intermittent claudication, headache, dizziness, paresthesia, depression, nightmares, syncope, diarrhea, constipation, nausea, dyspepsia, bloating, vomiting, dyspnea, bronchospasm, itching, erythematous rash, exacerbation of psoriasis, edema, fatigue, erectile dysfunction, vasogenic edema, hallucinations, psychosis, confusion, cyanosis of the extremities, dry eyes, practolol-induced conjunctival skin toxicity, Raynaud's phenomenon, dizziness, worsening heart failure, orthostatic hypotension, drug intolerance, first-degree AV block, lower limb edema, chest burning, insomnia, palpitations, abdominal pain, increased urination, elevated blood sugar, neck/shoulder pain, gastritis, chest pain, weakness, inadequate efficacy, weight loss, cough, cold, dry cough, loss of appetite, anxiety, back pain, elevated serum creatinine, tinnitus, vertigo, tremor, neuromuscular disease, gastroesophageal reflux, irritable bowel syndrome, thirst, gastric ulcer, gastrointestinal disorder, general weakness, facial edema, generalized edema, upper respiratory infection, rhinitis, sore throat, runny nose, restlessness, depression, drowsiness, arthralgia, flank pain, neck stiffness, lower back pain, elevated BUN, bladder discomfort, cystitis, urinary stones, hematuria, diabetes, hives, athlete's foot, sweating, tinea corporis, hypotension, hypertension, cerebrovascular disease, peripheral vascular disease, flushing, nosebleed, elevated ALT, elevated AST, viral infection, thyroiditis, chronic myeloid leukemia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness and safety.
White round tablet
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowNebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 2.725mg
Tablet · Prescription medication
Erison Pharm Co., Ltd.

Nebivolol Hydrochloride 1.3625mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.